Development of personalized tumor biomarkers using massively parallel sequencing - sprookjes - yvandenbroek - TriplyDB

Development of personalized tumor biomarkers using massively parallel sequencing

Development of personalized tumor biomarkers using massively parallel sequencing

http://www.wikidata.org/entity/Q28278819

about

Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cells New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway Distant metastasis occurs late during the genetic evolution of pancreatic cancer Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma Circulating tumor cells: approaches to isolation and characterization Characterization of complex chromosomal rearrangements by targeted capture and next-generation sequencing Sequencing technologies and genome sequencing Circulating biomarkers to monitor cancer progression and treatment Circulating tumor DNA in hepatocellular carcinoma: trends and challenges Cell-free circulating tumor DNA in cancer Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role New blood markers detection technology: A leap in the diagnosis of gastric cancer "Liquid biopsy"-ctDNA detection with great potential and challenges Translational implications of tumor heterogeneity Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics Liquid biopsies: genotyping circulating tumor DNA Epigenetics advancing personalized nanomedicine in cancer therapy Ovarian cancer biomarker discovery based on genomic approaches Emerging methods for disease monitoring in malignant gliomas Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer Testing for ROS1 in non-small cell lung cancer: a review with recommendations Precision targeted therapy of ovarian cancer Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models 'Omic approaches to preventing or managing metastatic breast cancer Deep sequencing of target linkage assay-identified regions in familial breast cancer: methods, analysis pipeline and troubleshooting Prostate cancer epigenetics and its clinical implications Individualized medicine from prewomb to tomb Detection of circulating tumor DNA in early- and late-stage human malignancies Blood-based biomarkers for malignant gliomas Identifying network-based biomarkers of complex diseases from high-throughput data.A 3D-engineered porous conduit for peripheral nerve repair.An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

P2860

Q21132550-14D36770-F092-4854-A8A0-DF6AFD4C7C0D Q21184064-0A5EF719-E667-4E72-BA48-AC6A23E211C4 Q24563539-80A12FA5-18D3-4515-BFC1-61485D83BFB7 Q24594878-4B5E6D16-7391-4399-910E-601F1DED50B7 Q24603649-433C320E-C493-42E3-A34D-0988888F144F Q24624284-B0CFA1C8-1367-4866-AEE0-66A32715687D Q24630017-1C64DFB4-5DFE-43A6-8F8E-462F3A202ABD Q24631347-49B2A434-A9B6-4718-8145-40AD6300CA88 Q24633977-954F7730-F20F-47C1-B872-75919022DEF0 Q24635185-848C2EE3-54D5-45AB-B63D-5968AD7F850D Q26745985-3E34DFB4-B877-4901-B77C-F8B56E8415BC Q26749417-1066FD17-31AF-487E-B280-79AE3DEE2247 Q26750899-58146658-588A-4DBD-9686-28975D978287 Q26769734-2DDDAF3C-DDE1-4DD9-BC0C-F715C4213347 Q26774503-0E3E6E78-4539-4A98-B7C1-3E441D3DB1BF Q26779222-89EE1AA5-FC00-4906-AB56-E5535B27BC76 Q26822823-CC180E67-0813-41FC-82A1-57012676150D Q26823978-70FF10E4-99FB-4254-AD81-4E74931FC9C8 Q26864332-64D09448-44B6-46DB-928A-5FCBF59BB3D0 Q27010159-CCE4E123-4BE8-4340-8296-7477A3744E7A Q27010637-CF6DFC19-BAB4-4A1A-B227-E8524F6321DB Q27013687-2374EDC2-DDE6-40B0-9B0B-D3EB08AA1FCF Q27023823-6B61B511-D228-495E-9503-7B24A460127E Q27024626-F76E3A25-7129-4204-A61D-21014D21418D Q28069755-0DD31AE3-CA8A-4F4F-A2B2-110CC5B7E7E2 Q28070062-650D8B49-83C5-45BC-A985-BB1C5866AF32 Q28078658-62EFE254-B13B-4E5F-990A-B05703D12C90 Q28239638-EE6B9319-B71E-474D-AFAA-FA6EF137EB7D Q28280303-56D9CB8E-E333-4144-AA69-FA629ECC7B4C Q28305453-B3BAD408-BB26-49D2-9952-B8E4665AD176 Q28486219-3489CA76-9410-488D-A9D6-DCE487D78A2F Q28730572-32A5B0FA-B79D-4B37-A714-C5FD7EC7EFF8 Q28748212-05B9DED5-6250-4289-B433-6FB7C79CD640 Q28829460-87132EBF-FE28-447D-879E-C19090CC06A9 Q29525070-93A0D390-A2AB-458D-A1BA-260011DDB4F6 Q29615778-D9223A40-4A16-429D-9D2F-F68B29DBC984 Q30625411-C96D253B-641D-4374-9629-783D614D758E Q31038202-F5BC4383-00D5-4C2C-B13F-CD4810997820 Q33555407-34B043C6-ECF2-434A-A740-DE93AA6B2F4C Q33590850-A0BDCD88-7CF3-4B62-9DD6-811D14D2853B

P2860

Development of personalized tumor biomarkers using massively parallel sequencing

http://www.wikidata.org/entity/Q28278819

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Development of personalized tumor biomarkers using massively parallel sequencing

@ast

Development of personalized tumor biomarkers using massively parallel sequencing

@en

Development of personalized tumor biomarkers using massively parallel sequencing

@nl

type

label

Development of personalized tumor biomarkers using massively parallel sequencing

@ast

Development of personalized tumor biomarkers using massively parallel sequencing

@en

Development of personalized tumor biomarkers using massively parallel sequencing

@nl

prefLabel

Development of personalized tumor biomarkers using massively parallel sequencing

@ast

Development of personalized tumor biomarkers using massively parallel sequencing

@en

Development of personalized tumor biomarkers using massively parallel sequencing

@nl

P1433

Q28278819-A02B1F75-05F7-47D8-831C-743ABA3A5878

P1476

Q28278819-99FB3212-C46C-4DA2-A2E5-1EEA906C6E10

P2093

Q28278819-0CA4342B-09A5-4D24-A3E2-CD91F3C273AB

Q28278819-3D37C4E7-8448-4E5C-BC57-4C9294ACA318

Q28278819-67B85964-9B89-4D58-82E8-0F3177547B13

Q28278819-68DBFD8F-9DD8-4D53-9699-B42FC6EA4C1B

Q28278819-6D415B15-DB4D-4C0C-94C5-CAD429DA540F

Q28278819-76514C04-08BA-49C9-8289-768CE7FEFE7C

Q28278819-7EF327FB-4517-4DA5-AEC2-A29D64AE3A0C

Q28278819-A5C133FF-1469-4D79-87E3-6FF5203A11EA

Q28278819-C24FF7B4-7CCD-4CDA-83FB-06D89D73687C

P2860

Q28278819-0B7C1A38-6573-41F2-91A4-F38E25280742

Q28278819-1357D9DA-BA06-4131-B1B4-527A41FC4C81

Q28278819-24F8EE18-116A-463A-94DD-445F2172D94C

Q28278819-2786D5A5-4B7C-4652-8DC2-9370CF2AD70D

Q28278819-2ACF21A4-9EED-4EE1-AB5C-FA5C1D58F82C

Q28278819-2E889D74-ADF7-42F8-9E8F-AA43472DD142

Q28278819-4DB39ABD-3DAF-436F-BA3E-31789FE70E43

Q28278819-4E86AC18-18C8-4B7D-B612-04872AF1126F

Q28278819-561B6FA4-8816-40FB-9880-AEA3D395D2DA

Q28278819-580612DC-A956-4B6D-B8FE-065EEC3EAA26

P304

Q28278819-A9D65E58-7F07-42D3-A361-CB1DEC7AD580

P31

Q28278819-1A325BDB-4971-45F0-AEBB-540F4D73EA9B

P3181

Q28278819-92E1A02B-9E79-4458-8355-CB2D71CA6882

P356

Q28278819-D644E3D8-D736-4E02-A255-E6876BED90D7

P407

Q28278819-0CE7A016-3EB9-4C7F-A284-1D186639BF16

P433

Q28278819-DC059058-F40E-4524-97B7-F5DA78E88C32

P478

Q28278819-8AF547C8-4141-450C-84A9-35EEB60474B6

P50

Q28278819-05B08CF3-2415-4D0C-8BD0-0BCFA0516E36

Q28278819-54A38195-0B43-4B30-B208-E326CCE9F93D

Q28278819-5E01C39F-AF93-4772-9397-256714D75A9B

Q28278819-A1A2C442-8F7B-48CD-8268-0474CFD47D14

Q28278819-C5F7D8D6-4CD5-4C11-A4D7-A1AFCAF6794C

P577

Q28278819-5BF98EC3-9A90-4568-B174-4D2A7686F9BF

P5875

Q28278819-C07DF6C1-9C3C-4005-8450-58C6BC53EB1F

P698

Q28278819-419F9FCA-E7FB-4299-8428-01E529E54EA8

P921

Q28278819-B1F89D52-B118-4243-BC19-9EDAE1234E70

P932

Q28278819-36B11E7B-C32B-4A3F-9D34-4746D0F9C5B3

P3181

P356

SCITRANSLMED.3000702

P1433

Science Translational Medicine

P1476

Development of personalized tumor biomarkers using massively parallel sequencing

@en

P2093

Alena Antipova

http://www.w3.org/2001/XMLSchema#string

Chris Clouser

http://www.w3.org/2001/XMLSchema#string

Cisilya Duncan

http://www.w3.org/2001/XMLSchema#string

Clarence Lee

http://www.w3.org/2001/XMLSchema#string

Francisco M De La Vega

http://www.w3.org/2001/XMLSchema#string

Frank Diehl

http://www.w3.org/2001/XMLSchema#string

Isaac Kinde

http://www.w3.org/2001/XMLSchema#string

Kerstin Schmidt

http://www.w3.org/2001/XMLSchema#string

Rebecca J Leary

http://www.w3.org/2001/XMLSchema#string

P2860

Digital karyotyping

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients

Complex landscapes of somatic rearrangement in human breast cancer genomes.

Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding

Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

Paired-end mapping reveals extensive structural variation in the human genome

Transcriptome sequencing to detect gene fusions in cancer

Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution

Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations

P304

20ra14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1140929

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCITRANSLMED.3000702

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth W Kinzler

Luis Alberto Diaz Jr

Victor Velculescu

Bert Vogelstein

P577

2010-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43049786

http://www.w3.org/2001/XMLSchema#string

P698

20371490

http://www.w3.org/2001/XMLSchema#string

P921

P932

2858564

http://www.w3.org/2001/XMLSchema#string